Product Code: ETC4471061 | Publication Date: Jul 2023 | Updated Date: Feb 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 85 | No. of Figures: 45 | No. of Tables: 25 | |
The UAE Apheresis Market is a crucial component of the healthcare industry, providing essential blood purification and collection services. Apheresis is used in various therapeutic and diagnostic applications, including blood component separation, autoimmune disease treatment, and organ transplant procedures. The market is growing due to advancements in apheresis technology, increasing cases of chronic diseases, and a robust healthcare system in the UAE. Apheresis plays a pivotal role in managing conditions that require precise blood component manipulation, making it a valuable market in the country.
The UAE apheresis market is experiencing robust growth due to several drivers. Firstly, the rising incidence of various autoimmune disorders, blood-related diseases, and organ transplantation procedures is creating a strong demand for apheresis procedures. Apheresis is a crucial treatment modality in many of these conditions, and the increasing prevalence of these diseases is a primary driver. Moreover, the UAE healthcare sector is characterized by continuous advancements in medical technology and infrastructure. The country`s commitment to providing high-quality healthcare services has led to the establishment of state-of-the-art medical facilities and a well-trained healthcare workforce. These developments are facilitating the growth of the apheresis market. Furthermore, medical tourism plays a significant role in the UAE healthcare sector, attracting patients from around the world. Apheresis, being a specialized and often life-saving procedure, is a key offering in the country`s medical tourism portfolio, driving the market`s expansion. Additionally, the increasing awareness among patients about the benefits of apheresis therapies is fostering greater acceptance of these procedures.
The Apheresis market in the UAE faces challenges related to the high cost of equipment and procedures, limiting their accessibility to a larger patient population. Moreover, the need for skilled technicians to operate these specialized systems adds another layer of complexity. Efforts to make apheresis procedures more affordable and training programs to enhance the pool of skilled technicians are imperative to overcome these challenges.
The apheresis market in the UAE faced challenges during the pandemic as non-essential medical procedures were limited. The market observed a temporary decline in demand for therapeutic apheresis and blood component collection systems. However, the market showcased resilience through the adoption of mobile apheresis units and remote donor management systems, contributing to the market`s recovery as healthcare services resumed.
Key players such as Fresenius SE & Co. KGaA, Haemonetics Corporation, and Terumo BCT, Inc. are leading the Apheresis market in the UAE. The market is characterized by the use of apheresis systems for therapeutic and donor apheresis procedures, including plasma exchange, red blood cell exchange, and plateletpheresis, contributing to the treatment of various medical conditions.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Arab Emirates (UAE) Apheresis Market Overview |
3.1 United Arab Emirates (UAE) Country Macro Economic Indicators |
3.2 United Arab Emirates (UAE) Apheresis Market Revenues & Volume, 2021 & 2031F |
3.3 United Arab Emirates (UAE) Apheresis Market - Industry Life Cycle |
3.4 United Arab Emirates (UAE) Apheresis Market - Porter's Five Forces |
3.5 United Arab Emirates (UAE) Apheresis Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 United Arab Emirates (UAE) Apheresis Market Revenues & Volume Share, By Method, 2021 & 2031F |
3.7 United Arab Emirates (UAE) Apheresis Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.8 United Arab Emirates (UAE) Apheresis Market Revenues & Volume Share, By Component, 2021 & 2031F |
3.9 United Arab Emirates (UAE) Apheresis Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United Arab Emirates (UAE) Apheresis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 United Arab Emirates (UAE) Apheresis Market Trends |
6 United Arab Emirates (UAE) Apheresis Market, By Types |
6.1 United Arab Emirates (UAE) Apheresis Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United Arab Emirates (UAE) Apheresis Market Revenues & Volume, By Product, 2021-2031F |
6.1.3 United Arab Emirates (UAE) Apheresis Market Revenues & Volume, By Devices, 2021-2031F |
6.1.4 United Arab Emirates (UAE) Apheresis Market Revenues & Volume, By Disposable and Reagents, 2021-2031F |
6.1.5 United Arab Emirates (UAE) Apheresis Market Revenues & Volume, By Software, 2021-2031F |
6.2 United Arab Emirates (UAE) Apheresis Market, By Method |
6.2.1 Overview and Analysis |
6.2.2 United Arab Emirates (UAE) Apheresis Market Revenues & Volume, By Centrifugation, 2021-2031F |
6.2.3 United Arab Emirates (UAE) Apheresis Market Revenues & Volume, By Membrane Separation, 2021-2031F |
6.2.4 United Arab Emirates (UAE) Apheresis Market Revenues & Volume, By Selective Adsorption, 2021-2031F |
6.3 United Arab Emirates (UAE) Apheresis Market, By Procedure |
6.3.1 Overview and Analysis |
6.3.2 United Arab Emirates (UAE) Apheresis Market Revenues & Volume, By Donor/Automated Apheresis, 2021-2031F |
6.3.3 United Arab Emirates (UAE) Apheresis Market Revenues & Volume, By Therapeutic Apheresis, 2021-2031F |
6.4 United Arab Emirates (UAE) Apheresis Market, By Component |
6.4.1 Overview and Analysis |
6.4.2 United Arab Emirates (UAE) Apheresis Market Revenues & Volume, By Plasma (Plasmapheresis), 2021-2031F |
6.4.3 United Arab Emirates (UAE) Apheresis Market Revenues & Volume, By Platelets (Plateletpheresis), 2021-2031F |
6.4.4 United Arab Emirates (UAE) Apheresis Market Revenues & Volume, By Leukocytes (Leukapheresis or leukopheresis), 2021-2031F |
6.4.5 United Arab Emirates (UAE) Apheresis Market Revenues & Volume, By Lymphocytes (Lymphopheresis or lymphapheresis), 2021-2031F |
6.4.6 United Arab Emirates (UAE) Apheresis Market Revenues & Volume, By RBC's (Erythropheresis), 2021-2031F |
6.5 United Arab Emirates (UAE) Apheresis Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 United Arab Emirates (UAE) Apheresis Market Revenues & Volume, By Blood Centers, 2021-2031F |
6.5.3 United Arab Emirates (UAE) Apheresis Market Revenues & Volume, By Hospitals, 2021-2031F |
6.5.4 United Arab Emirates (UAE) Apheresis Market Revenues & Volume, By Other End Users, 2021-2031F |
7 United Arab Emirates (UAE) Apheresis Market Import-Export Trade Statistics |
7.1 United Arab Emirates (UAE) Apheresis Market Export to Major Countries |
7.2 United Arab Emirates (UAE) Apheresis Market Imports from Major Countries |
8 United Arab Emirates (UAE) Apheresis Market Key Performance Indicators |
9 United Arab Emirates (UAE) Apheresis Market - Opportunity Assessment |
9.1 United Arab Emirates (UAE) Apheresis Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 United Arab Emirates (UAE) Apheresis Market Opportunity Assessment, By Method, 2021 & 2031F |
9.3 United Arab Emirates (UAE) Apheresis Market Opportunity Assessment, By Procedure, 2021 & 2031F |
9.4 United Arab Emirates (UAE) Apheresis Market Opportunity Assessment, By Component, 2021 & 2031F |
9.5 United Arab Emirates (UAE) Apheresis Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United Arab Emirates (UAE) Apheresis Market - Competitive Landscape |
10.1 United Arab Emirates (UAE) Apheresis Market Revenue Share, By Companies, 2024 |
10.2 United Arab Emirates (UAE) Apheresis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |